Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry.

Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NA, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Law I, Loomis M, Barth C, Brandt C, Dziura J, Li F, Cannom D.

Circulation. 2013 May 21;127(20):2021-30. doi: 10.1161/CIRCULATIONAHA.112.000447.

2.

Changing Views: Safety and Efficacy of Implantable Cardioverter- Defibrillator Therapy in Athletes.

Pavlů L, Hutyra M, Táborský M.

Cent Eur J Public Health. 2015 Nov;23 Suppl:S74-7. Review.

3.

Athletic participation in the young patient with an implantable cardioverter-defibrillator.

Lampert R, Law I.

Cardiol Young. 2017 Jan;27(S1):S132-S137. doi: 10.1017/S1047951116002377. Review.

PMID:
28084971
4.

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.

J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.

5.

Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members.

Lampert R, Cannom D, Olshansky B.

J Cardiovasc Electrophysiol. 2006 Jan;17(1):11-5.

PMID:
16426392
6.

Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.

Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.

Heart. 2009 May;95(9):709-14. doi: 10.1136/hrt.2008.150656. Epub 2009 Mar 11.

PMID:
19282314
7.

Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.

Schwartz PJ, Spazzolini C, Priori SG, Crotti L, Vicentini A, Landolina M, Gasparini M, Wilde AA, Knops RE, Denjoy I, Toivonen L, Mönnig G, Al-Fayyadh M, Jordaens L, Borggrefe M, Holmgren C, Brugada P, De Roy L, Hohnloser SH, Brink PA.

Circulation. 2010 Sep 28;122(13):1272-82. doi: 10.1161/CIRCULATIONAHA.110.950147. Epub 2010 Sep 13.

8.

Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.

Kleemann T, Hochadel M, Strauss M, Skarlos A, Seidl K, Zahn R.

J Cardiovasc Electrophysiol. 2012 Jul;23(7):735-40. doi: 10.1111/j.1540-8167.2011.02279.x. Epub 2012 Feb 7.

PMID:
22313314
9.

Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.

Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA.

J Am Coll Cardiol. 2008 Apr 29;51(17):1685-91. doi: 10.1016/j.jacc.2008.01.033.

10.

Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.

Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC Jr, Brieke A, Sauer WH.

J Heart Lung Transplant. 2010 Jul;29(7):771-6. doi: 10.1016/j.healun.2010.02.001. Epub 2010 Mar 29.

PMID:
20347337
11.

Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL; AVID Investigators.

J Cardiovasc Electrophysiol. 2003 Sep;14(9):940-8.

PMID:
12950538
12.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators.

J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073.

13.

Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).

Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I, Khalamizer V, Fuchs T, Boulos M, Geist M, Strasberg B, Ilan M, Belhassen B; Israeli Working Group on Cardiac Pacing and Electrophysiology.

Isr Med Assoc J. 2008 Jun;10(6):435-9. Erratum in: Isr Med Assoc J. 2008 Jul;10(7):549.

14.

Implantable cardioverter defibrillator in sport participation.

Mascia G, Di Biase L, Galanti G, Natale A, Padeletti L.

Int J Sports Med. 2014 Aug;35(9):800-6. doi: 10.1055/s-0033-1361185. Epub 2014 Apr 15. Review. Erratum in: Int J Sports Med. 2014 Aug;35(9):806.

PMID:
24920562
15.

Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators.

Love BA, Barrett KS, Alexander ME, Bevilacqua LM, Epstein MR, Triedman JK, Walsh EP, Berul CI.

J Cardiovasc Electrophysiol. 2001 Oct;12(10):1097-101.

PMID:
11699514
16.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.

17.

Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.

MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P, Birnie D, Simpson CS, Khaykin Y, Pinter A, Nanthakumar K, Calzavara AJ, Austin PC, Tu JV, Lee DS.

Ann Intern Med. 2012 Feb 7;156(3):195-203. doi: 10.7326/0003-4819-156-3-201202070-00007.

PMID:
22312139
18.
19.

Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.

Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD.

J Am Coll Cardiol. 1999 Jan;33(1):24-32.

20.

Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?

Koyak Z, de Groot JR, Van Gelder IC, Bouma BJ, van Dessel PF, Budts W, van Erven L, van Dijk AP, Wilde AA, Pieper PG, Sieswerda GT, Mulder BJ.

Circ Arrhythm Electrophysiol. 2012 Feb;5(1):101-10. doi: 10.1161/CIRCEP.111.966754. Epub 2011 Nov 17.

Supplemental Content

Support Center